OHSU Knight Cancer Institute researcher Andrew Emili to deliver May 10 talk

Slide for Network Systems Biology talk by Andrew Emili

A leader in functional proteomics, systems biology, and protein mass spectrometry, Emili will discuss how his research group's ‘interactome’ maps can be applied to drug discovery

Internationally recognized researcher Andrew Emili will deliver a talk at 11 a.m. on Wednesday, May 10 in the Knight Campus Beetham Family Seminar Room. The title of his talk is "Network Systems Biology: Mapping Macromolecular Interactions for Drug Discovery."

photo of Andrew Emili

Emili leads the Collaboratory for Network Systems Biology (CNSB) at the Knight Cancer Institute (KCI) at Oregon Health & Science University (OHSU), where his team aims to map macromolecular interactions crucial to human health and disease, most notably cancer. The Emili group develops innovative technologies to map cellular protein interaction networks on a global-scale, publishing ‘interactome’ maps of unprecedented quality, scope and resolution.

Dr. Emili has developed and applied innovative proteomics, functional genomics and bioinformatics methods to investigate biological systems and molecular association networks in human cells and model organisms. In particular, the Emili Lab uses quantitative, high precision mass spectrometry to characterize protein complexes in a comprehensive, high-throughput manner. His group aims for breakthrough insights into the composition and mechanistic role of protein complexes in diverse cells and tissues, with the long-term goal of translating this basic knowledge into new diagnostics, prognostics and therapeutics.

Prior to August 2022, Emili was the Founding Director of the Center for Network Systems Biology and a founding member of the Faculty of Computing and Data Sciences at Boston University. Prior to 2017, he was a founding faculty member and principal investigator for 17 years at the Donnelly Center for Cellular and Biomolecular Research at the University of Toronto.

Emili received a Ph.D. in Molecular Genetics from the University of Toronto and a Bachelor’s degree in Immunology and Microbiology from McGill University. He pursued post-doctoral studies as a Damon Runyon/Walter Winchell Research Fellow with the Nobel laureate geneticist Leland Hartwell at the Fred Hutchinson Cancer Research Center in Seattle, while learning protein mass spectrometry with John Yates III at the University of Washington.

Read more about the CNSB

 More on the Emili Research Group